Anzeige
Mehr »
Freitag, 06.03.2026 - Börsentäglich über 12.000 News
"Unbegrenzte Munition?" - Ohne diesen kritischen Rohstoff bleibt es wohl nur ein Versprechen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40H7V | ISIN: SE0022574331 | Ticker-Symbol: 4HG0
Frankfurt
05.03.26 | 08:15
0,169 Euro
+2,43 % +0,004
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
QLIFE HOLDING AB Chart 1 Jahr
5-Tage-Chart
QLIFE HOLDING AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,1600,21007:46

Aktuelle News zur QLIFE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
QLIFE Aktie jetzt für 0€ handeln
DoQLife Holding AB: The subscription period in Qlife's rights issue begins today55NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
MiQLife Holding AB: Qlife publishes information document due to upcoming rights issue63NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
27.02.QLife Holding AB: Qlife announces that two investors have entered agreements to subscribe for shares if the rights issue is subscribed below approx. 51.0 percent, taking over commitments from a group of guarantors90NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
27.02.XFRA CAPITAL ADJUSTMENT INFORMATION - 27.02.2026207Das Instrument UZ9 CA4577022078 INSPIRATION ENERGY CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 27.02.2026 und ex Kapitalmassnahme am 02.03.2026 The instrument UZ9 CA4577022078 INSPIRATION ENERGY...
► Artikel lesen
26.02.QLife Holding AB: Bulletin from Extraordinary General Meeting 2026 of Qlife Holding AB87Qlife Holding AB (the "Company" or "Qlife") held an Extraordinary General Meeting on 26 February 2026, at which the following resolutions were adopted. Resolution on amendment of the Articles of Association The...
► Artikel lesen
25.02.QLIFE HOLDING AB: Qlife launches pharmacy pilot project in Nordic markets2
19.02.QLIFE HOLDING AB: Guarantor converts guarantee commitment of SEK 0.5 million into binding subscription commitment and top guarantor waives guarantee compensation in Qlife's ongoing rights issue1
12.02.The observation status for Qlife Holding AB is updated120On June 5, 2025, the shares in Qlife Holding AB (the "Company") were given observation status with reference to the Company's decision to enter into a letter of intent for a reverse takeover of Hipro...
► Artikel lesen
11.02.Qlife Holding AB Q4 Sales Decline-
11.02.QLife Holding AB: QLIFE HOLDING AB, Interim Report Q4, October - December 2025124Positioned for scale in 2026 The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter Financial summary - fourth quarter 2025 On 5. October...
► Artikel lesen
26.01.Notice of Extraordinary General Meeting 2026 in Qlife Holding AB2
26.01.QLife Holding AB: Qlife submits Egoo PHE home testing system for regulatory approval343Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, today announces that the Company has formally submitted its Egoo PHE home-testing system for regulatory approval...
► Artikel lesen
22.01.QLife Holding AB: Qlife resolves on a partially guaranteed rights issue of approx. SEK 31.4 million and proposes an over-allotment option, enters bridge loan agreements and postpones the exercise period of warrants TO7108NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
19.01.QLIFE HOLDING AB: Qlife prepares for pharmacy testing in Nordic markets1
15.01.QLife Holding AB: Egoo Health achieves breakthrough precision in key diabetes biomarker test, paving the way for partnerships137Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, together with its partner Hipro Biotechnology Co., Ltd. ("Hipro"), announces a major milestone: the Egoo HbA1c...
► Artikel lesen
23.12.25QLife Holding AB: Qlife provides end-year operational update on key issues531Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, provides a year-end operational update on key issues. Diabetes data Egoo Health has achieved breakthrough...
► Artikel lesen
16.12.25QLife Holding AB: Qlife and Hipro sign exclusive commercial agreement covering Qlife's sale of Hipro products in EU and US markets191Qlife Holding AB ("Qlife" or the "Company"), a first mover in clinical-grade home diagnostics, today announced that it has entered into an exclusive commercial agreement with Hipro Biotechnology Co....
► Artikel lesen
16.12.25QLife Holding AB: The Letter of Intent with Hipro Biotechnology regarding the reverse takeover has been extended until 31 December 2026 and the valuation term will re-evaluated once a structure has been established252Qlife Holding AB ("Qlife" or the "Company") announces an extension of the non-binding Letter of Intent regarding the potential reverse takeover (the "Transaction") with Hipro Biotechnology Co., Ltd....
► Artikel lesen
12.12.25QLife Holding AB: Egoo Health powers AI-driven personalized diabetes management in China220Qlife Holding AB ("Qlife" or the "Company") is proud to announce that its Egoo Health blood testing platform will play a central role in a groundbreaking project launched by Hipro Biotechnology Co....
► Artikel lesen
05.12.25QLife Holding AB: Qlife's Birmingham PKU clinical trial published with strong results - key milestone toward CE-mark submission and market launch154Qlife Holding AB ("Qlife" or the "Company") a first mover in clinical-grade home diagnostics, announces publication of the clinical study for PKU children and adolescents under 18 years of age. The...
► Artikel lesen
Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1